气道清除设备市场机会、成长动力、产业趋势分析与 2025 - 2034 年预测

2024 年全球气道清理设备市场规模达到 6.486 亿美元，预计 2025-2034 年期间的复合年增长率为 4.8%。这种增长是由多种因素推动的，包括持续的技术进步、慢性呼吸系统疾病发病率的上升、人口老化以及医院内感染发病率的上升等。

市场按设备类型细分，主要类别包括肺内衝击通气 (IPV)、高频胸壁振盪 (HFCWO)、机械咳嗽辅助装置、扑动黏液清除装置、呼气正压 (PEP) 等。其中，HFCWO 细分市场在 2024 年引领市场，创造了可观的收入。 HFCWO 设备因其非侵入性而越来越受欢迎，它为患者提供了一种舒适的气道清除方法。这些设备使用方便，无需患者主动参与即可提供一致的治疗，特别适合老年和儿科患者。

依年龄层来看，市场分为成人市场和儿童市场。成人市场在 2024 年占据最大份额，预计在整个预测期内将继续占据主导地位，到 2034 年市场价值将达到 6.54 亿美元。家庭治疗的日益普及进一步推动了这种需求。成年人越来越喜欢便携式、用户友好的气道清除设备，这种设备使他们能够舒适地在家中管理慢性呼吸系统疾病，从而减少频繁去医院的需要。

2024 年北美气道清除设备市场规模为 2.546 亿美元，预计 2025-2034 年期间的复合年增长率为 3%。北美的慢性呼吸系统疾病发生率很高，这大大增加了对先进的气道清除技术的需求。该地区完善的医疗保健基础设施和广泛使用的创新医疗设备使其成为在临床和家庭护理环境中采用气道清除设备的理想环境。预计这一趋势将推动市场持续成长，改善整个地区的患者管理和治疗效果。

目录

第 1 章：方法论与范围

第 2 章：执行摘要

第 3 章：产业洞察

• 产业生态系统分析
• 产业衝击力
  • 成长动力
    • 呼吸系统疾病发生率上升
    • 提高患者意识和产品发布
    • 非侵入性治疗方案的采用率不断提高
    • 政府加强控制呼吸系统疾病
  • 产业陷阱与挑战
    • 设备成本高且监管要求严格
• 成长潜力分析
• 2023 年定价分析
• 监管格局
  • 我们
  • 欧洲
• 报销场景
• 技术格局
• 价值链分析
• 应用潜力
• 措施/政策前景
• 差距分析
• 未来市场趋势
• 波特的分析
• PESTEL 分析

第四章：竞争格局

• 介绍
• 公司矩阵分析
• 公司市占率分析
• 竞争定位矩阵
• 供应商矩阵分析
• 策略仪表板

第 5 章：市场估计与预测：按设备类型，2018 – 2032 年

• 主要趋势
• 高频胸壁振动（HFCWO）
• 扑动黏液清除装置
• 肺内衝击通气 (IPV)
• 机械性咳嗽辅助装置
• 呼气正压（PEP）
• 其他设备类型

第六章：市场估计与预测：按应用，2018 – 2032 年

• 主要趋势
• 慢性阻塞性肺病（COPD）
• 支气管扩张
• 囊肿纤维化
• 神经肌肉
• 其他应用

第七章：市场估计与预测：依年龄组，2018 – 2032 年

• 主要趋势
• 成人
• 儿科

第 8 章：市场估计与预测：依最终用途，2018 – 2032 年

• 主要趋势
• 医院
• 家庭护理设置
• 门诊手术中心
• 其他最终用途

第 9 章：市场估计与预测：按地区，2018 – 2032 年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第十章：公司简介

• ABM Respiratory Care
• Baxter International/Hill-Rom Holdings
• Dima Italia
• Dymedso
• Electromed
• ICU Medical
• Koninklijke Philips NV
• Mercury Medical
• Monaghan Medical
• Pari Medical
• Pneumo Care Health
• Sentec
• Tactile Medical
• Thayer Medical
• VORTRAN Medical
• VYAIRE MEDICAL

The Global Airway Clearance Devices Market reached USD 648.6 million in 2024 and is projected to grow at a CAGR of 4.8% during 2025-2034. This growth is driven by several factors, including ongoing technological advancements, the rising prevalence of chronic respiratory diseases, an aging population, and the increasing incidence of hospital-acquired infections, among others.

The market is segmented by device type, with key categories including intrapulmonary percussive ventilation (IPV), high-frequency chest wall oscillation (HFCWO), mechanical cough assist devices, flutter mucus clearance devices, positive expiratory pressure (PEP), and others. Among these, the HFCWO segment led the market in 2024, generating significant revenue. HFCWO devices are gaining popularity due to their non-invasive nature, offering patients a comfortable airway clearance method. These devices are easy to use and deliver consistent therapy without requiring active participation from the patient, making them particularly suitable for elderly and pediatric patients.

In terms of age group, the market is divided into adult and pediatric segments. The adult segment held the largest share in 2024 and is expected to continue its dominance throughout the forecast period, reaching a market value of USD 654 million through 2034. Adults, particularly those recovering from thoracic or abdominal surgeries or respiratory infections, often need airway clearance therapy to avoid complications. This demand is further fueled by the growing trend of home-based treatments. Adults increasingly prefer portable, user-friendly airway clearance devices that enable them to manage chronic respiratory conditions from the comfort of their own homes, reducing the need for frequent hospital visits.

North American airway clearance devices market accounted for USD 254.6 million in 2024 and is expected to grow at a CAGR of 3% during 2025-2034. North America has a high incidence of chronic respiratory conditions, which significantly contributes to the demand for advanced airway clearance technologies. The region's well-established healthcare infrastructure and widespread access to innovative medical devices make it an ideal environment for the adoption of airway clearance devices in both clinical and home care settings. This trend is expected to drive continued market growth, improving patient management and outcomes across the region.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rise in incidence of respiratory conditions
    • 3.2.1.2 Growing patient awareness and product launches
    • 3.2.1.3 Increasing adoption of non-invasive treatment options
    • 3.2.1.4 Surge in government initiatives towards controlling respiratory disorders
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High device cost and stringent regulatory requirements
• 3.3 Growth potential analysis
• 3.4 Pricing analysis, 2023
• 3.5 Regulatory landscape
  • 3.5.1 U.S.
  • 3.5.2 Europe
• 3.6 Reimbursement scenario
• 3.7 Technological landscape
• 3.8 Value chain analysis
• 3.9 Application potential
• 3.10 Initiatives/policy landscape
• 3.11 GAP analysis
• 3.12 Future market trends
• 3.13 Porter's analysis
• 3.14 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive positioning matrix
• 4.5 Vendor matrix analysis
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Device Type, 2018 – 2032 ($ Mn, Units)

• 5.1 Key trends
• 5.2 High frequency chest wall oscillation (HFCWO)
• 5.3 Flutter mucus clearance device
• 5.4 Intrapulmonary percussive ventilation (IPV)
• 5.5 Mechanical cough assist devices
• 5.6 Positive expiratory pressure (PEP)
• 5.7 Other device types

Chapter 6 Market Estimates and Forecast, By Application, 2018 – 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Chronic obstructive pulmonary disease (COPD)
• 6.3 Bronchiectasis
• 6.4 Cystic fibrosis
• 6.5 Neuromuscular
• 6.6 Other applications

Chapter 7 Market Estimates and Forecast, By Age Group, 2018 – 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Adult
• 7.3 Pediatric

Chapter 8 Market Estimates and Forecast, By End Use, 2018 – 2032 ($ Mn)

• 8.1 Key trends
• 8.2 Hospital
• 8.3 Homecare settings
• 8.4 Ambulatory surgical centers
• 8.5 Other end use

Chapter 9 Market Estimates and Forecast, By Region, 2018 – 2032 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Netherlands
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE

Chapter 10 Company Profiles

• 10.1 ABM Respiratory Care
• 10.2 Baxter International/Hill-Rom Holdings
• 10.3 Dima Italia
• 10.4 Dymedso
• 10.5 Electromed
• 10.6 ICU Medical
• 10.7 Koninklijke Philips N.V.
• 10.8 Mercury Medical
• 10.9 Monaghan Medical
• 10.10 Pari Medical
• 10.11 Pneumo Care Health
• 10.12 Sentec
• 10.13 Tactile Medical
• 10.14 Thayer Medical
• 10.15 VORTRAN Medical
• 10.16 VYAIRE MEDICAL